Acivir Pump Leaflet/ Tube leaflet
Consumer Medicine Information
Acivir contains the antiviral agent Aciclovir. When it is applied to the cold sore at the tingle stage, it enters the virus infected cells and is converted to aciclovir triphosphate which is responsible for preventing the virus from multiplying. Therefore it is important to start treatment at the first onset of symptoms - the tingle stage.
Cold Sores are lesions produced by a virus called the Herpes Simplex Virus. Usually blisters appear in the lip area and are sometimes referred to as fever blisters. Although most of the population carry the virus, differences in the efficiency of the immune system may be the reason that some individuals suffer from recurrence of cold sores.
Clearance of the lesions after the first attack does not result in a cure. After the first attack the virus retreats into a nerve junction until it is reactivated by some trigger factors. These trigger factors include other infections such as cold and flu, stress, stomach upset, physical abrasions, general ill health, other medicines or UV radiation ( in sunlight).
The first warning signs of a recurrence is an itching, burning and tingling sensation with pain. This stage is usually followed by skin ulceration and crusting after 24 to 36 hours. During this stage the virus is most active and discomfort most intense. The lesions usually heal within 7 - 14 days. Cold sores are infectious and patients can pass on the infection to other people through kissing or sharing of eating or drinking utensils or towels.
Cipla Genpharm Australia Pty Ltd
182 Alison Road
Carrara. QLD 4211
Acivir™ is a trademark of Cipla Genpharm Australia Pty Ltd
This leaflet was prepared in April 2003
Published by MIMS August 2004